BridgeBio Pharma, Inc. (BBIO)

64.50 -1.00 (-1.53%) USD  |  NASDAQ  |  Mar 03, 16:00
64.85 +0.35 (+0.54%) After-Hours: 20:00
More

BridgeBio Pharma Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade